Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-013920
Filing Date
2024-12-17
Accepted
2024-12-17 16:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27703
2 filename2.txt TEXT-EXTRACT 1196
  Complete submission text file 0000000000-24-013920.txt   40240
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filed for) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-283741
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)